Clinical Trial Update: A Prospective, Multicenter, Randomized, Open-label Study of 12 Week Duration to Evaluate the Effect of VILDagliptin Added to Insulin on Glycaemic Control in haemoDIALyzed Patients With Type 2 Diabetes: Probe Analysis of CGM [Phase 4]

View source ↗

Summary

A Phase 4 multicenter randomized study evaluating whether adding vildagliptin to insulin improves glycemic control in patients with Type 2 diabetes requiring he…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)
• Vildagliptin (vildagliptin)

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Haemodialyzed, Type 2 Diabetes | Phase 4 | Status: COMPLETED